Skip to main content
. 2012 Mar 6;7(3):e32745. doi: 10.1371/journal.pone.0032745

Table 1. Demographics and clinical presentation of subjects studied.

Subject/Gender Age Trigeminal division affected Laterality Medications Effect of treatment Post GKRS numbness Post treatment MR gadolinium enhancement
S1/F 43 V1, V2, V3 Left Intolerant/poor effectiveness Significant improvement initially, pain recurred at 1 year No Yes
S2/F 77 V2, V3 Right Carbamazepine 800 mg daily No pain at one year post treatment No No
S3/M 53 V1, V2 Right Carbamazepine 600 mg daily No pain at 6 months No No
S4/F 82 V2 Left Intolerant/poor effectiveness No pain at 6 months No Yes
S5/F 83 V1 Left Intolerant/poor effectiveness No pain at 6 months No Yes